ASX-Dividend-Report-Banner

NABR Files Expanded Petition Challenging the Listing of Long-Tailed Macaques by the IUCN

February 02, 2024 12:01 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp
 NABR Files Expanded Petition Challenging the Listing of Long-Tailed Macaques by the IUCN
Image source: Kalkine Media

WASHINGTON, Feb. 2, 2024 /PRNewswire/ -- Working with recognized, independent scientists, the National Association for Biomedical Research (NABR) filed an expanded petition today with the International Union for Conservation of Nature (IUCN) challenging the designation of the long-tailed macaque (Macaca fascicularis) as "endangered" or "vulnerable" under IUCN listing criteria. 

On October 12, 2023, the IUCN Standards and Petitions Committee accepted NABR's initial petition challenging the IUCN's 2022 designation of long-tailed macaques as "endangered." NABR's initial petition, filed with the IUCN on September 11, 2023, concluded that the underlying scientific justification for the Endangered listing is "biased" and "not based upon the best available scientific information."

Prior to July 2022, long-tailed macaques were designated as "vulnerable" by the IUCN. In 2022, the IUCN revised its designation to "endangered" based upon a scientific review published by Hansen et al. (2022).1 The expanded NABR petition now calls for the IUCN to vacate both the "endangered" and "vulnerable" listings until "a new status assessment of M. fascicularis is conducted by truly independent scientists not involved in advocacy roles for the target species."

The expanded NABR petition follows a recent publication in The American Journal of Primatology, a prominent scientific journal, that reviews scientific information used to determine the conservation status of the long-tailed macaque.2 This publication concludes that "none of the published literature cited to support the IUCN listing as Endangered presents any data to support the hypothesized decline, nor does the literature establish that the species is at risk of becoming extinct."

"The NABR scientific review team is pleased that the IUCN Standards and Petitions Committee will now objectively review this matter," stated Dr. Ray Hilborn, a world-renowned scientist and member of NABR's scientific review team. 

"Given the misrepresentation of the data that has occurred in the 2022 and 2020 assessments, we expect that the IUCN Standards and Petitions Committee will agree with our conclusions" added Dr. Hilborn.

The submission of NABR's expanded petition initiates a formal process with the IUCN Standards and Petitions Committee to review available scientific information concerning the species' status under IUCN protocols.

Long-tailed macaques are the most widely used non-rodent species for drug development as well as for drug safety and efficacy testing. They are also extensively used in cancer research, immunology science, regenerative medicine and genetic disease research.

Long-tailed macaques are considered as an invasive species in many countries and regions including Hong Kong3, Indonesia4,5, Mauritius6, Papua New Guinea,7 and Thailand8. For decades, Asian and African countries have bred specific pathogen free long tailed macaques and exported them to the United States and other countries for biomedical research in laboratories. 

"The NABR petition and 2023 article published in The American Journal of Primatology demonstrate that long-tailed macaques are neither endangered nor vulnerable, but rather a highly invasive species that thrives in the majority of countries where they live," stated Matthew R. Bailey, president of the National Association for Biomedical Research.

"We call upon the IUCN Standards and Petitions Committee to vacate the improper listing of this species as either endangered or vulnerable and undertake a new status assessment of this species by independent scientists."

More information regarding the NABR petition is available online at www.nabr.org

About the National Association for Biomedical Research
Founded in 1979, the National Association for Biomedical Research (NABR) is the only 501(c)(6) nonprofit association dedicated to sound public policy for the humane use of animals in biomedical research, education, and testing. Members include more than 340 universities, medical and veterinary schools, teaching hospitals, pharmaceutical and biotechnology companies, patient groups, and academic and professional societies who rely on humane and responsible animal research to advance global human and animal health. Learn more about us at www.nabr.org.

1 See Hansen, M. F., Ang, A., Trinh, T. T. H., Sy, E., Paramasivam, S., Ahmed, T., Dimalibot, J., Jones–Engel, L., Ruppert, N., Griffioen, C., Lwin, N.,Phiapalath, P., Gray, R., Kite, S., Doak, N., Nijman, V., Fuentes, A., & Gumert, M. D. (2022). Macaca fascicularis (amended version of 2022 assessment). The IUCN Red List of Threatened Species 2022. https://www.iucn.org/resources/conservation-tool/iucn-red-list-threatened-species

2 See Hilborn, R., & Smith, D. R. (2023). Is the long–tailed macaque at risk of extinction? American Journal of Primatology, e23590. https://doi.org/10.1002/ajp.23590

https://www.afcd.gov.hk/english/conservation/con_fau/con_fau_mon/con_fau_mon_wild/con_fau_mon_wild.html

https://cites.org/sites/default/files/ndf_material/NDF_MEP_Indonesia_2023%20%281%29.pdf

5 https://www.researchgate.net/publication/346803479_Human_and_long-tailed_macaque_conflict_in_Central_Java_Indonesia 

6 https://link.springer.com/article/10.1007/s10764-022-00324-9

7 http://www.indopacific.org/wp-content/uploads/2017/02/papuamacaques-English-Version.pdf

8 https://www.thainationalparks.com/species/crab-eating-macaque


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.